Formulation Development

Inhal has a comprehensive expertise in formulation development, and is capable of developing Carrier-free drug formulation and Carrier-based formulation. Carrier-free formulation only contains micronized fine drug particles, which can be used in combination with matching inhaler devices to achieve excellent pulmonary drug delivery. Carrier-based formulation uses large lactose (30-300 μm) as carriers to improve its flowability for easy handing, dispensing and metering of the drug. In most cases, the fine drug particles are attached onto the surface of the large lactose to form an ordered mixture that helps improve bulk property.